Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Centogene NV C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development June 20, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting May 31, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights May 15, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position May 15, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease May 14, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG EVO CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients May 10, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Receives Nasdaq Non-Compliance Notice April 02, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders March 19, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG TAK CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency February 29, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing February 28, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Explores Strategic Alternatives February 28, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration January 25, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Receives French Research Tax Credit Accreditation January 24, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics January 23, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Announces Preliminary Full Year 2023 Revenue January 18, 2024 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Announces Voting Results of Extraordinary General Meeting December 19, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone December 13, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction November 28, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism November 14, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering October 10, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Reports First Half 2023 Financial Results September 07, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients September 01, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency August 31, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE to Participate in Upcoming Conferences in August August 07, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Regains Compliance With Nasdaq Listing Requirements July 14, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort July 12, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting June 30, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment June 27, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency June 14, 2023 From Centogene NV Via GlobeNewswire Tickers CNTG Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.